Skip to content

Becton, Dickinson and Company BDX Cumulative Cost Basis

Cumulative Cost Basis at other companies

Abbott logo
AbbottABT
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Merit Medical Systems logo
Merit Medical SystemsMMSI
OraSure Technologies logo
OraSure TechnologiesOSUR
InfuSystem Holdings logo
InfuSystem HoldingsINFU

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.0%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.6%
Free cash flow$546.0M

Valuation

See full
Market cap$41.7B-10.6%
Enterprise value$55.39B-12.5%
P/E36.6×+7.2×
P/S-0.3×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's cumulative cost basis?
Becton, Dickinson and Company (BDX) reported cumulative cost basis of $13.55B in Q1 2026.
How has Becton, Dickinson and Company's cumulative cost basis changed year-over-year?
Becton, Dickinson and Company's cumulative cost basis decreased by 5.9% year-over-year, from $14.41B to $13.55B.
What is the long-term trend for Becton, Dickinson and Company's cumulative cost basis?
Over 4 years (2021 to 2025), Becton, Dickinson and Company's cumulative cost basis has grown at a 3.1% compound annual growth rate (CAGR), from $12.09B to $13.66B.